Probiotics Dietary Supplementation for Modulating Endocrine and Fertility Microbiota Dysbiosis

Human microbiota seems to play a key role in endocrine and reproductive systems. Fortunately, microbiota reproductive dysbiosis start to be treated by probiotics using typical species from genus Lactobacillus. This work presents the compiled and analysed results from the most up-to-date information...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrients Jg. 12; H. 3; S. 757
Hauptverfasser: López-Moreno, Ana, Aguilera, Margarita
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland MDPI AG 13.03.2020
MDPI
Schlagworte:
Bias
Clinical trials
Dietary Supplements
dysbiosis
Dysbiosis - complications
Dysbiosis - therapy
endocrine diseases
Endocrine System - microbiology
Endocrine System Diseases - microbiology
Endocrine System Diseases - therapy
Endometriosis
Endometrium
Female
Fertility
Functional foods & nutraceuticals
Genitalia, Female - microbiology
Humans
Infertility
Infertility, Female - microbiology
Infertility, Female - therapy
information
Intervention
Lactobacillus
mastitis
Metabolism
Microbiota
Microorganisms
nutrients
Ovaries
Physiology
Polycystic ovary syndrome
Pregnancy
Probiotics
Probiotics - therapeutic use
Review
sample size
strains
Treatment Outcome
Vagina
women
microbiota
doses
fertility
dysbiosis
endocrine
probiotics
ISSN:2072-6643, 2072-6643
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Human microbiota seems to play a key role in endocrine and reproductive systems. Fortunately, microbiota reproductive dysbiosis start to be treated by probiotics using typical species from genus Lactobacillus. This work presents the compiled and analysed results from the most up-to-date information from clinical trials regarding microbiota, fertility, probiotics and oral route administration, reviewing open access scientific documents. These studies analyse the clinical impact of probiotics administered on several endocrine disorders’ manifestations in women: mastitis; vaginal dysbiosis; pregnancy complication disorders; and polycystic ovary syndrome. In all cases, the clinical modulation achieved by probiotics was evaluated positively through the improvement of specific disease outcomes with the exception of the pregnancy disorders studies, where the sample sizes results were statistically insufficient. High amounts of studies were discarded because no data were provided on specific probiotic strains, doses, impact on the individual autochthon microbiota, or data regarding specific hormonal values modifications and endocrine regulation effects. However, most of the selected studies with probiotics contained no protocolised administration. Therefore, we consider that intervention studies with probiotics might allocate the focus, not only in obtaining a final outcome, but in how to personalise the administration according to the disorder to be palliated.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2072-6643
2072-6643
DOI:10.3390/nu12030757